Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 6, 2023; 11(1): 116-126
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.116
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.116
Characteristic | Parameters | n (%) |
Age | Min-max: 20-84 | 200 (100) |
Median: 62 | ||
mean ± SD: 59.6 ± 12.1 | ||
Duration of port use in mo | Min-max: 0-93 | 200 (100) |
Median: 8 | ||
mean ± SD: 13.5 ± 15.7 | ||
Sex | Female | 99 (49.5) |
Male | 101 (50.5) | |
Side | Right | 186 (93.0) |
Left | 14 (7.0) | |
Number of chemotherapeutic drug(s) | 1 | 87 (43.5) |
2 | 83 (41.5) | |
3 | 30 (15.0) | |
Complication | Present | 20 (10) |
Absent | 180 (90) | |
Clavien-Dindo severity classification | 0-I | 179 (89.5) |
II | 7 (3.5) | |
III | 14 (7.0) |
- Citation: Erdemir A, Rasa HK. Impact of central venous port implantation method and access choice on outcomes. World J Clin Cases 2023; 11(1): 116-126
- URL: https://www.wjgnet.com/2307-8960/full/v11/i1/116.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i1.116